Notably, two studies comparing the progression of neuropathy in T1DM patients undergoing ITx versus those receiving intensive insulin therapy (IIT) reported differing outcomes: while neuropathy tended to improve in the IIT group, a worsening was observed in the non-transplanted T1DM controls [19, 31]. This evidence concerns the gene INS and type 1 diabetes mellitus.